5:01 Acquisition Corp.
Status: Liquidated
U=S
| IPO Proceeds, $M | $82.56M |
|---|---|
| IPO Date | Oct 14, 2020 |
| CEO | Andrew J. Schwab; Kush M. Parmar, M.D., Ph.D. |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Biotechnology in North America and Europe |
| IPO Geography | US/Canada |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Oct 17, 2022 |
FVAM
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on 5:01 Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 8 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Andrew J. Schwab | 49 | Co-CEO and Director |
| Kush M. Parmar, M.D., Ph.D. | 39 | Co-CEO and Director |
| Galya D. Blachman, Ph.D., Esq. | 43 | General counsel and secretary |
| Rebecca L. Lucia | 48 | CFO and Treasurer |
| Jason R. Ruth, Ph.D. | 35 | Chief Business Officer |
| Daniella Beckman | 42 | Director |
| Matthew Patterson | 49 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| BofA Securities | BR | 8,000,000 | units |
| 8,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 8 filings.